Nawandar DM et al.Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.J Virol 91:N/A (2017).
Bilger A et al.Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Oncotarget 8:44266-44280 (2017).
Martin KA et al.Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.J Virol 90:8520-30 (2016).
Campion EM et al.Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor ß1-induced B-cell apoptosis.J Virol 88:5001-13 (2014).
Arredouani MS et al.Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.J Virol 88:5559-77 (2014).
Flanagan J et al.Localization of the Epstein-Barr virus protein LMP 1 to exosomes.J Gen Virol 84:1871-9 (2003).
Xu J et al.Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.J Virol 76:4080-6 (2002).
Nakatsuka S et al.Pyothorax-associated lymphoma: a review of 106 cases.J Clin Oncol 20:4255-60 (2002).
Ascani S et al.Pyothorax-associated lymphoma: description of the first two cases detected in Italy.Ann Oncol 8:1133-8 (1997).
Rowe M et al.Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.J Gen Virol 68 ( Pt 6):1575-86 (1987).
Rowe M et al.Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.EMBO J 6:2743-51 (1987).